42.34
Qiagen Nv (QGEN) 最新ニュース
QIAGEN N.V. Prepares to Release 2024 Financial Reports - TipRanks
PTA-AFR: QIAGEN N.V.: Pre-announcement of a financial report according to articles 114117 WpHG - TradingView
Baird Increases Price Target for Qiagen (QGEN) Ahead of Q1 Results | QGEN Stock News - GuruFocus
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen’s Voting Rights Announcement Involves Major Financial Entities - TipRanks
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Fivespan Is Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen's Future Under The Microscope After Stake Purchase - Finimize
Fivespan Partners Positions Itself in Qiagen (QGEN) Amid Activis - GuruFocus
Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake - marketscreener.com
Activist investor Fivespan takes stake in QiagenBloomberg (QGEN:NYSE) - Seeking Alpha
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - 01net
QIAGEN's Lab Revolution: New Automation Systems Promise 3x Faster Sample Processing - Stock Titan
Qiagen (QGEN) Target Price Reduced Amid Negative Market Sentimen - GuruFocus
BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating - MarketScreener
QIAGEN Announces Voting Rights Notification by AFM - TipRanks
Qiagen gains after guidance raise - MSN
Qiagen Announces Change in Total Voting Rights - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - sharewise.com
QIAGEN Earnings Alert: Key Q1 2025 Results Coming May 7What to Watch - Stock Titan
Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted -- Shares Rise - MarketScreener
Qiagen stock gains after guidance raise (QGEN:NYSE) - Seeking Alpha
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance - Benzinga
Qiagen: Q1 beat; profitability guidance upgraded - MarketScreener
QIAGEN NV : Deutsche Bank maintains a Buy rating - marketscreener.com
QIAGEN NV : UBS gives a Neutral rating - MarketScreener
Qiagen the only DAX stock to risehigher profit forecast helps - MarketScreener
QIAGEN NV : Jefferies gives a Buy rating - marketscreener.com
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook - Yahoo Finance
EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook - sharewise.com
QIAGEN Crushes Q1 Targets: Key Products Surge, EPS Guidance Raised to $2.35 - Stock Titan
Qiagen Says Q1 Adjusted EPS $0.55 - MarketScreener
QIAGEN N.V.: QIAGEN Announces Strong Preliminary Q1 2025 Results and Updates Full-Year 2025 Adjusted Earnings per Share Outlook - The Globe and Mail
Redburn Atlantic Downgrades Qiagen N.V. (BIT:1QGEN) - Nasdaq
Redburn Atlantic Downgrades Qiagen N.V. (LSE:0RLT) - Nasdaq
Qiagen Announces Voting Rights Update with Bank of America - TipRanks
Redburn cuts QIAGEN stock rating, lowers price target to EUR41 - Investing.com
Redburn cuts QIAGEN stock rating, lowers price target to EUR41 By Investing.com - Investing.com Australia
Redburn-Atlantic Downgrades QIAGEN NV (QIA:GR) (QGEN) to Neutral - StreetInsider
Lab Automation Market Top PlayersF. Hoffmann-La Roche, Qiagen - openPR.com
Qiagen introduces QIAprep Plasmodium kit to strengthen malaria research efforts - BioSpectrum Asia
大文字化:
|
ボリューム (24 時間):